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Abstract
In vivo knowledge of the spatial distribution of viable, necrotic, and hypoxic areas can provide prognostic informa-
tion about the risk of developing metastases and regional radiation sensitivity and may be used potentially for
localized dose escalation in radiation treatment. In this study, multimodality in vivo magnetic resonance imaging
(MRI) and positron emission tomography (PET) imaging using stereotactic fiduciary markers in the Dunning R3327-
AT prostate tumor were performed, focusing on the relationship between dynamic contrast-enhanced (DCE) MRI
using Magnevist (Gd-DTPA) and dynamic 18F-fluoromisonidazole (18F-Fmiso) PET. The noninvasive measurements
were verified using tumor tissue sections stained for hematoxylin/eosin and pimonidazole. To further validate the
relationship between 18F-Fmiso and pimonidazole uptake, 18F digital autoradiography was performed on a selected
tumor and compared with the corresponding pimonidazole-stained slices. The comparison of Akep values (kep =
rate constant of movement of Gd-DTPA between the interstitial space and plasma and A = amplitude in the two-
compartment model (Hoffmann U, Brix G, Knopp MV, Hess T and Lorenz WJ (1995). Magn Reson Med 33, 506–
514) derived from DCE-MRI studies and from early 18F-Fmiso uptake PET studies showed that tumor vasculature is
a major determinant of early 18F-Fmiso uptake. A negative correlation between the spatial map of Akep and the
slope map of late (last 1 hour of the dynamic PET scan) 18F-Fmiso uptake was observed. The relationships between
DCE-MRI and hematoxylin/eosin slices and between 18F-Fmiso PET and pimonidazole slices confirm the validity of
MRI/PET measurements to image the tumor microenvironment and to identify regions of tumor necrosis, hypoxia,
and well-perfused tissue.
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Introduction
It is anticipated that the ability to image the tumor microenviron-
ment in vivo will provide useful prognostic information including
an assessment of factors that influence response to treatment. For ex-
ample, hypoxia, typically distributed heterogeneously in locally ad-
vanced tumors, is known to affect both radiation sensitivity and
the development of metastases [1–4]. Tumor hypoxia results from
an imbalance between the supply and use of oxygen in tumor tissues.
Thus, major determinants of tumor hypoxia include the structure
and functionality of tumor vasculature and the degree of angiogenesis
[5–8]. The direct measurement of tumor hypoxia usually requires
invasive procedures such as the insertion of polarographic electrodes.
However, such invasive methods are restricted both spatially and
temporally, being limited to a relatively small number of measure-
ments on easily accessible tumors at, typically, a single point in time.
Noninvasive imaging offers several advantages, including the feasibil-
ity of longitudinal measurements on the same subject, the generation
of complete three-dimensional maps of tumor hypoxia, and the po-
tential application to image-guided therapy. Imaging modalities, such
as magnetic resonance imaging (MRI), positron emission tomogra-
phy (PET), electron paramagnetic resonance, and optical imaging,
have their own unique advantages. Magnetic resonance imaging pro-
vides unique functional and structural information on tumor vascu-
lature and physiology at high spatial resolution. Positron emission
tomography can measure sensitively and quantitatively local concen-
trations of radioactive molecular targets of interest, such as labeled
fluoromisonidazole (18F-Fmiso).
18F-Fmiso PET is currently under intense investigation as a method
of imaging tumor hypoxia. This is based on the selective bioreduc-
tion of 18F-Fmiso in hypoxic tumor regions followed by the bind-
ing of its metabolites to macromolecules [9–12]. However, the
spatial resolution, based on the full-width half-maximum (FWHM)
of the point spread function of the PET activity signal, is relatively
coarse, ranging from 1 to 2 mm for dedicated small-animal scanners
to 5 to 6 mm for clinical PET scanners. Magnetic resonance tech-
niques provide unique opportunities to obtain noninvasive structural
and functional information on tumor vasculature and physiology
with anatomical details at finer spatial resolution. Magnetic reso-
nance methods, which include dynamic contrast-enhanced MRI
(DCE-MRI) [13,14], blood oxygen level–dependent imaging [15],
fluorine-19 MR measurements of oxygen-sensitive compounds
[16–18], and the measurement of lactate [19,20], may provide
high-spatial resolution functional information to complement other
imaging modalities.
In particular, DCE-MRI provides vasculature/perfusion informa-
tion of the tumor microenvironment [21,22] and, thus, not only of-
fers complementary information to PET hypoxia imaging but also
may address the relationship between tumor hypoxia and vasculature.
In this article, we focus on the relationship between DCE-MRI stud-
ies using Gd-DTPA as the contrast agent, and dynamic 18F-Fmiso
PET, in the syngeneic Dunning R3327-AT prostate tumor in rats.
The in vivo imaging results were validated by ex vivo studies featuring
staining with hematoxylin/eosin (H&E) (tumor necrosis) and pimo-
nidazole (tumor hypoxia) together with 18F digital autoradiography
(DAR; 18F-Fmiso distribution) on tumor tissue sections accurately
registered to the corresponding in vivo slices. Accurate registration
of macroscopic (MRI and PET) and microscopic images (H&E, pi-
monidazole and 18F DAR) is a unique and important feature of the
current study.
Experimental Methods
Animal Preparation
Animal studies were conducted in compliance with protocols ap-
proved by the Institutional Animal Care and Use Committee of
Memorial Sloan-Kettering Cancer Center (MSKCC). The rat prostate
cancer cell line R3327-AT [23] was cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum, 100 U/ml
penicillin, and 100 μg/ml streptomycin at 37°C in a humidified CO2
incubator. Cells were harvested on reaching 75% to 80% confluence
and suspended in phosphate-buffered saline (PBS) at a final concen-
tration of 2 × 106 cells/0.1 ml. Two to four million R3327-AT cells
were injected in the right hind leg of 6- to 8-week-old Copenhagen
rats. Tumor volume (V ) was calculated as V = (π/6) × x × y ×
z, where x, y, and z were the three orthogonal dimensions of the
tumor [24]. The experiments were performed over a tumor size
range of 500–2500 mm3. A total of six rats were used. At the start
of each experiment, the tail vein was catheterized with a 24G catheter
and connected to a three-way stopcock (Stopcock Nylon 3-Way,
420163-4503; Kimble Kontes LLC, NJ), facilitating intravenous
(IV) injection of the different agents at various stages of the multi-
modality imaging experiment. The catheter was kept patent by in-
jecting heparinized saline.
Magnetic Resonance Coil and Fiduciary Marker Assembly
The MRI coil [diameter (D) = 4 cm, Helmholtz configuration]
was constructed in two parts (Figure 1A) with the upper part of
the MRI coil and marker assembly initially detached to facilitate sub-
sequent positioning of the animal. The spatial marker assembly is
shown in Figure 1A attached to the rest of coil-marker system, and
Figure 1B shows an enlarged side view of the marker assembly alone
(adapted from [25,26]). The marker assembly was composed of two
cylindrical disks and one flat plate. The top disk, referred to as the
marker holder disk [D = 1.5 cm, thickness (t) = 0.9 cm] had three
holes (D = 0.9 mm) for the vertical markers. A bottom histology
marker disk (D = 1.5 cm, t = 0.5 cm) with identically aligned holes
was separated from the marker holder disk by a flat plate. Separate
release screws fastened each disk to the flat plate, which was fixed to
the top of the radiofrequency coil. At the end of the imaging experi-
ments, the histology marker disk was detached from the rest of the
marker assembly and served as a reference to align the tumor sections
with the in vivo image slices as described below (procedure detailed in
the Preparation of Tumor Cryosections section). The flat plate had
one side hole to contain a horizontal marker. An additional holder
was placed at the center of the bottom coil with a grooved disk
(D = 1 cm, t = 0.3 cm) containing another horizontal marker as shown
in Figure 1A. The three vertical (forming an oblique triangle with
lengths of 0.9, 0.7, and 0.5 cm, respectively) and two leveled hori-
zontal markers (22G catheter; Terumo Surflo I.V. Catheter, Somerset,
NJ) were filled with Gd-DTPA–doped and red-colored water, sealed at
the ends with Critoseal (Cascade Healthcare, Portland, OR), and
placed at each of the designated positions in the marker holders.
The three vertical markers were pushed into the 0.9-mm-sized holes
through the two separate cylindrical disks (the marker holder and his-
tology marker disks). The three vertical and two horizontal markers
appear as the red tubes in Figure 1A. The distance between the top
and bottom coil was adjustable over a range of 2 to 3 cm to accom-
modate tumors of various sizes.
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Animal Immobilization
The animal was placed on a plexiglass holder, and a rapidly set-
ting mold was formed to keep it in place on the plastic wrap–lined
animal holder with a respiration monitor pad (SA Instruments, Inc.,
Stony Brook, NY) placed under the animal’s abdomen. The animal
was anesthetized with isoflurane (1%-2%), lined in plastic wrap, and
placed prone on the holder with its tumor-bearing hind leg out-
stretched above the bottom part of the MR coil (Figure 1C ). The
animal-positioning mold was made by mixing SecureFoam foaming
reagents (Bionix Radiation Therapy, Toledo, OH) “A” and “B” (15 g
each) together and pouring them on the plexiglass holder lateral to
the animal [27], effectively immobilizing the animal and its leg. After
allowing 5 to 7 minutes for the mold to cure, the top part of the MRI
coil including the marker assembly was attached back to the circuitry
and placed on the top of tumor (Figure 1D).
Dynamic Contrast-Enhanced MRI
TheDCE-MRI experiments were performed on a Bruker 7TBioSpin
(Bruker, Germany) imaging spectrometer. A syringe filled with the
contrast agent Gd-DTPA (0.2 mM Gd/kg, Magnevist; Berlex Labo-
ratories, Inc., Wayne, NJ) was connected to the three-way stopcock
throughGd-DTPA–filled tubing (MasterflexNorprene tubing, 6402-13).
The entire assembly including the anesthetized animal was positioned
inside the magnet using a spirit level and the axial MR profile. Respi-
ration was monitored during the MR experiment. Warm air flowed
through the magnet’s bore to maintain the animal’s temperature under
isoflurane anesthesia. TheMRI coil was tuned andmatched to the pro-
ton frequency, followed by shimming of the sample. The coronal slices
of interest were determined from a pilot scan. Spin density images [fast
low-angle shot MRI, repetition interval (TR) = 500 milliseconds, echo
time (TE) = 3.1 milliseconds, number of repetitions (NR) = 1, number
of averages (NA) = 1, slice thickness (ST) = 0.79 mm, field of view
(FOV) = 3.5 cm × 3.5 cm, matrix = 128 × 128, number of slices =
64, flip angle = 30°] were acquired to encompass the MRI marker
and tumor for subsequent image registration with PET and histology.
T2-weighted MR images (rapid acquisition with refocused echoes,
TR = 2000 milliseconds, TE = 30 milliseconds, NR = 1, NA = 1,
ST = 0.79 mm, number of slices = 4, FOV = 3.5 cm × 3.5 cm, ma-
trix = 128 × 128) were acquired for four tumor slices to visualize clearly
the boundary between tumor and muscle. T1-weighted DCE-MRI
(fast low-angle shots, TR = 33 milliseconds, TE = 3.1 milliseconds,
NR = 256, NA = 1, ST = 0.79 mm, number of slices = 4, FOV =
3.5 cm × 3.5 cm, matrix = 128 × 128, flip angle = 30°) was performed
at 5.47 seconds of temporal resolution with an in-plane resolution of
273 μm × 273 μm in plane. The contrast agent Gd-DTPA was in-
jected through the tail vein after 2 minutes of baseline acquisition
followed by 20 minutes of dynamic acquisition. After the DCE-MRI
studies, additional proton spin density images were reacquired and com-
pared with the previous images to ensure that the tumors were in the
identical position with respect to the marker system before and after
Figure 1. Photographs illustrating animal positioning and molding process on the home-built MR/PET animal holder with stereotactic
marker system. (A) An enlarged picture of the stereotactic coil-marker system for MR/PET with actual markers (22G catheter, appearing
as red tubes) placed in position. (B) Side view of the marker holder and histology disk. The tumor without (C) and with marker assembly
in place (D) is shown after securing the animal on the holder. The release screws for vertical marker holder and histology disk were used
to disengage each piece independently.
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the DCE-MRI study. The tubing and syringe for the administration of
the contrast agent Gd-DTPA were replaced by a syringe filled with
pimonidazole (Hypoxyprobe, NPI, Inc., Burlington, MA). The still
anesthetized animal in the holder was transported under anesthesia to
the microPET facility on a mobile anesthesia cart. We have previously
shown that this procedure prevents the displacement of the tumor with
respect to the marker assembly [26].
Dynamic microPET
Fluorine-18-Fmiso was produced by the Radiochemistry Service at
MSKCC on an EBCO TR 19/9 cyclotron (EDCO Technologies,
Vancouver, Canada) as reported previously [28]. For PET studies,
the MRI markers were replaced with catheter tubings filled with
18F-Fmiso diluted with red dye to an activity of ∼10 μCi/ml. The
animal was positioned with its tumor centered in the gantry of the
microPET Focus 120 (CTI Molecular Imaging, Inc., Knoxville, TN)
and the animal bed horizontally aligned with respect to the MRI
plane. An initial 2-minute static acquisition was performed to acquire
the diluted 18F-Fmiso marker images for image coregistration before
the injection of the 18F-Fmiso and dynamic imaging. Thus, the rel-
atively high-activity (∼1.5 mCi) 18F-Fmiso injected for the dynamic
imaging did not distort the images of the marker and the low-activity
markers had no effect on the dynamic 18F-Fmiso imaging. The in-
jection of 18F-Fmiso (∼1.5 mCi) through one port of the three-way
stopcock was immediately followed by the injection of pimonidazole
(60 mg/kg) through another port of the stopcock. Dynamic PET
scanning was initiated immediately before the injection of the 18F-
Fmiso and continued for 2 to 3 hours. Figure 2A shows a “control”
dynamic PET time-activity curve of one vertical marker demonstrat-
ing the stability of the PET acquisition. The list mode data were
acquired using an energy window of 350 to 750 keV and a coinci-
dence timing window of 6 nanoseconds and were reconstructed in a
three-dimensional image matrix with voxel dimensions of 0.86 mm ×
0.86 mm × 0.79 mm.
Preparation of Tumor Cryosections
After the PET scan, the animal assembly was removed from the
scanner and the PETmarkers were removed by releasing the vertical
marker holder disk (previously described in the Animal Preparation
section) from the coil-marker assembly while keeping the histology
disk with its identical pattern of holes in place on the tumor. The ani-
mal was then euthanized in place by isoflurane overdose, and imme-
diately after sacrifice, three catheters with steel needles were pushed
through the histology marker disk into the tumor. The resulting
catheter histology disk-tumor assembly ensured the coregistration
of tissue sections with the in vivo MR and PET images. After the
insertion of the catheter and needles, the bottom histology marker
disk was released from the coil-marker assembly, and the animal
was removed from the holder for tumor excision. The tumor was
excised with the catheter histology disk-tumor assembly intact,
washed once in PBS, placed into OCT (Tissue-Tek O.C.T. Com-
pound, Sakura Finetek U.S.A., Inc., Torrance, CA) and frozen in
dry ice. After the catheter histology disk-tumor assembly was frozen,
the steel needles were removed leaving the catheter tubing in place.
To properly orient the tissue section plane with respect to the MRI/
PET imaging plane, the histology disk was oriented parallel to the
cutting surface of the tumor while freezing in dry ice. The frozen
tissues were stored at −80°C until later processing.
Autoradiography, Immunofluorescence, and Histology
The frozen OCT-embedded tumors were sectioned on a Microm
HM500 cryostat microtome (Microm International GmbH, Walldorf,
Germany). Sets of contiguous 8-μm-thick sections were cut at 0.79-mm
increments across the tumor to ensure that the histology slices were
sampled at positions corresponding to mid slice of the MRI and PET
tomograms. To acquire the distribution of 18F-Fmiso on a selected
tumor, one section from each set was placed onto an imaging phosphor
plate for DAR. Twenty-four hours later, the DAR images were read out
in a 50-μm-pixel-sizemode using a Fujifilm BAS-1800 II phosphor plate
reader (Fuji Photo Film Co. Ltd., Tokyo, Japan). After autoradiogra-
phy, sections were fixed in 4% paraformaldehyde solution for 10 min-
utes at room temperature and then blocked in SuperBlock-PBS (Pierce
Biotechnology, Inc., Rockford, IL) for 1 hour. The pimonidazole distri-
bution was detected by incubating with an antipimonidazole mono-
clonal antibody conjugated to fluorescein isothiocyanate (Chemicon,
Figure 2. (A) The PET signal of one of the vertical markers for the
duration of the PET measurement demonstrating the stability of the
PET acquisition; the greater dispersion of points at earlier times
after injection reflects the corresponding shorter time frames and
lower count statistics. (B) The AIF of PET sampled from the tail re-
gion of a rat. This AIF was used for the compartment modeling of
the dynamic PET time-activity curves reducing the open parameters
to be fitted to four. ID indicates injected dose.
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Temecula, CA), diluted 1:10 in SuperBlock. Images of stained tumor
sections were acquired at a high magnification (×100) using an Olympus
BX40 fluorescence microscope (Olympus America Inc., Melville, NY)
equipped with a motorized stage (Prior Scientific Instruments Ltd.,
Cambridge, UK) and an appropriate filter. The individually captured
image frames were rendered into a montage of the entire tumor section
(0.85 μm × 0.85 μm per pixel) using ImagePro software (Media Cyber-
netics Inc, Bethesda, MD). The sections were then stained with H&E
for the identification of tumor necrosis and were imaged by light micros-
copy (0.85 μm × 0.85 μm per pixel). An image mask was generated
based on the pimonidazole-stained section to distinguish the hypoxic
from the nonhypoxic areas in the tumor. To reproducibly generate
masks of positive pimonidazole staining, the images were converted to
black and white, and a threshold for the intensity of pimonidazole back-
ground staining was obtained by measuring the average intensity of
staining in the necrotic region of the tumor. The necrotic tumor region
was determined from the corresponding H&E stained section. The re-
sulting mask of positive pimonidazole staining was applied to the slope
map of the late 18F-Fmiso PET images to separate values corresponding
to hypoxic tumor regions from those corresponding to nonhypoxic tu-
mor regions. For viable tumor regions, a similar mask was generated
from the H&E image and applied to the corresponding DCE Akep
map to distinguish values of viable tumor tissue from those of necrosis.
Data Analysis
Dynamic Contrast-Enhanced MRI Analysis
The DCE-MRI data analysis was performed using in-house writ-
ten Matlab (The MathWorks, Inc., Natick, MA) scripts. Dynamic
signal intensity curves were obtained from the T1-weighted signal in-
tensity of each voxel in the dynamic MR images of the tumor slices
after Gd-DTPA administration. The experimental dynamic build-up
curves for each voxel in the MR images were normalized to the base-
line signal and fitted using the model developed by Hoffman et al.
[29] for each slice. This model is based on the linear relationship be-
tween measured saturation recovery MR signal and the concentration
of Gd-DTPA in the tissue. An amplitude (A), which reflects the de-
gree of relative MR signal enhancement and an exchange rate (kep),
which characterizes the velocity of MR signal increase, can be derived
from the two-compartment model. Consequently, the value of Akep
is analogous to the slope of time-dependent MR signal enhancement
and is considered an approximate measure of blood flow/perfusion of
the tumor tissue [29]. The Hoffman model was used to estimate
Akep values of individual voxels from the dynamic build up curves,
and Akep maps were generated for the corresponding tumor slices.
Dynamic PET Analysis
List mode data were sorted into two-dimensional histograms by
Fourier rebinning using a span of 3 and a maximum ring difference
of 47. Images were reconstructed by filtered back-projection using a
ramp filter with the Nyquist frequency as the cutoff frequency in a
128 × 128 × 95 matrix. The image data were corrected for nonuni-
formity of scanner response with cylinder source-based normaliza-
tion, a global correction for dead-time count losses based on the
singles count rate and physical decay to the time of injection. The
count rates in the reconstructed images were converted to activity
concentration (% of injected dose per gram of tissue, %ID/g) using
a system calibration factor derived from a rat-size cylindrical phan-
tom measurement containing a known activity concentration in
aqueous 18F solution. The phantom measurement also revealed that
no attenuation or scatter correction was necessary. Voxel-based anal-
ysis of reconstructed dynamic PET images was performed using in-
house written Matlab scripts. Kinetic curves of 18F-Fmiso intensity
for individual voxels for each acquired tomographic slice through the
tumor (0.86 mm × 0.86 mm × 0.79 mm, 45-49 time frames during
the 2∼3 hours of total acquisition time) were obtained. The initial
18F-Fmiso uptake into the tumor was evaluated for each animal from
the first 5 minutes of the dynamic PET scan. This analysis is based
on the hypothesis that the initial distribution of 18F-Fmiso is mainly
driven by tumor perfusion, so that the early uptake of 18F-Fmiso is
representative of tumor vasculature and perfusion. The later 18F-
Fmiso uptake was analyzed for each animal by fitting the linear slope
of the last 1 hour of data from the PET time-activity curve. The anal-
ysis of the later 18F-Fmiso uptake data was based on the hypothesis
that the accumulation of 18F-Fmiso in the hypoxic region results in a
positive slope at later time after injection, whereas a well-perfused,
normoxic tumor region exhibits dynamic curves with a high initial
uptake followed by washout and necrotic areas display little to no
initial uptake with only gradual subsequent uptake. Thus, we hy-
pothesized that the positive slope of later time points in the dynamic
PET curve of a voxel identifies areas of tumor hypoxia. The validity
of this hypothesis will be demonstrated in the Experimental Results
section. To quantify perfusion and tumor hypoxia, the foregoing
analysis of the PET data was complemented by compartment mod-
eling of the dynamic PET signal. The model of Thorwarth et al. [30]
describes the tissue as consisting of a diffusive and an accumulative
compartment based on a kinetic model with four variables fitting the
experimental kinetic curves for each voxel. This model is used to ex-
tract the grade of perfusion, w0 (weighting factor of vascularized re-
gion), and the extent of hypoxia, wa × k3 (where wa is the number of
viable hypoxic cells and k3 is the modified 18F-Fmiso accumulation
rate constant, i.e., mean degree of hypoxia), respectively [30]. The
grade of perfusion and the extent of hypoxia thus identified were
then compared directly with the initial uptake and later slope maps,
respectively, of the 18F-Fmiso time-activity curve. The arterial input
function (AIF) for the 18F-Fmiso compartment modeling was de-
rived by region of interest analysis over a central blood vessel in
the dynamic PET (Figure 2B).
Image Coregistration
Magnetic resonance and PET images were coregistered using a rigid
transform derived from the three-dimensional marker systems as shown
in stacked MR slices in Figure 3A. The slice thickness of the MR images
was chosen to match the nominal slice thickness of 0.79 mm of the
PET image slices, facilitating the alignment of the MR with the PET
image. The maximum error for this slice coregistration can be estimated
as follows. Considering that the inner diameter of a 22G catheter (MR
marker) was 0.6 mm and the slice thickness was 0.79 mm, a maximum
error of ±0.1 mm can occur if the marker is located off center in the
slice. (Note that the MR slice for the top horizontal marker was chosen
in such a way that the MR signal from the marker was confined to one
slice and no detectable MR signal from adjacent slices was observed.)
For the PET markers, the worst case error would occur if the center
of the catheter (PET marker) were located just between two adjacent
PET slices, resulting in a maximum error of ±0.4 mm. After matching
the slices, the MR and PET images were aligned in plane, using the
three vertical marker images of both MR and PET images. Owing to
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the different in-plane resolutions of PET and MR, PETmarker images
were interpolated to match the in-plane resolution of the MR voxel
using nearest-neighbor interpolation followed by the calculation of
the maximum correlation coefficient for the two images with vary-
ing translational and rotational shift of the PET marker images. The
resulting optimized rotational and translational shifts were then ap-
plied to the tumor slices thereby aligning the MR and PET images
(Figure 3B).
Experimental Results
Figure 4, A and B, shows the DCE-MRI time-signal curves and
18F-Fmiso PET time-activity curves for a representative voxel from per-
fused, hypoxic, and necrotic regions of a tumor, respectively. The voxel
for the perfused area was chosen from the high-intensity region of the
DCE-MRI Akep map as shown in Figure 4C and the voxel represent-
ing the hypoxic region was selected from the area staining strongly
for pimonidazole (Figure 4D) as well as from the parametric images
of PET 18F-Fmiso late slope maps as shown Figure 4E . The voxel
representing tumor necrosis was chosen from the H&E-stained sec-
tions (Figure 4F ). In the DCE-MR study, the T1-weighted proton
signal increased fastest in the nonnecrotic area as a result of rapid
Gd-DTPA uptake in the well-perfused region followed by rapid wash-
out. In contrast, hypoxic regions, typically characterized by reduced
vascularization, showed a delayed Gd-DTPA uptake corresponding
to a delay in signal build-up and also to a delay in washout
(Figure 4A). In necrotic regions of the tumor, the time-dependent in-
crease in the MR signal was slowest, and no washout could be ob-
served for the duration of the MR experiment. In 18F-Fmiso PET
studies, well-perfused areas of the tumor were likewise characterized
by a rapid initial increase of 18F-Fmiso activity, which subsequently
decreased at later times. Hypoxic areas of the tumor demonstrated
lower initial activity than well-perfused areas of the tumor but contin-
ued to accumulate further 18F-Fmiso during the time course of the
experiment, as manifested by the distinctive positive slope (Figure 4B).
Consequently, there was a point (∼1 hour for this tumor) of crossover
between the decreasing intensity of 18F-Fmiso activity in well-perfused
area and increasing intensity in hypoxic areas. The existence of this
crossover behavior illustrated that a single static activity image at a late
time point after 18F-Fmiso injection may not reliably identify hypoxia
because it may reflect 18F-Fmiso activity in well-perfused areas that has
not completely washed out. Necrotic regions of the tumor showed the
least activity during the time course of the PET experiment; however,
some activity is still observed. These observations agree with the hy-
pothesis that the initial uptake of 18F-Fmiso is mainly dependent on
tumor vasculature and perfusion. The accumulation of 18F-Fmiso ac-
tivity in hypoxic regions exhibits a characteristic positive slope at later
times, providing a signature for hypoxic regions without the need for
complex modeling analyses. Also, as expected, necrotic areas show very
low initial uptake of activity and a persisting low signal level.
Figure 5 compares early uptake (A) and later slope (C) of the 18F-
Fmiso time-activity curve with the compartment model parameters
w0 (the grade of perfusion, Figure 5B) and wa × k3 (the extent of
hypoxia, Figure 5D), respectively [30]. Tumor perfusion was well re-
presented by the early uptake of 18F-Fmiso, as well as w0, with both
parameters being closely related (Figure 5E , Pearson’s correlation
with R ∼ 0.8, P < .001). There was also a strong correlation between
the late slope of the 18F-Fmiso time-activity curve and the model-
derived parameter wa × k3 (Figure 5F, Pearson’s correlation with R ∼
0.75, P < .001). With the five open parameters in the PET compart-
ment model, with one of them estimated by the measured AIF, cau-
tion needs to be exercised to obtain physiologically relevant values for
each parameter. This is particularly problematic in severely hypoxic
and necrotic tumor regions for which the signal-to-noise ratio is rel-
atively low. In such cases, the early uptake rate and the late slope of
the time-activity curves may provide similar, yet more robust mea-
sures of the respective tumor microenvironments as the latter param-
eters involve fewer degrees of freedom in the fitting procedure than
the compartmental modeling.
In Figure 5, G–I , respectively, a 18F digital autoradiogram (DAR),
pimonidazole- and H&E-stained tissue section, and the correspond-
ing in vivo MRI and 18F-Fmiso PET tumor images are shown. The
spatial congruence between the late (3 hours) static PET image
(Figure 5J ) and the activity distribution in the 18F-autoradiogram
Figure 3. (A) Representative stacked two-dimensional slice images
of MR markers are shown. Tumors grown on hind legs of rats are
placed between the two horizontal markers. (B) The aligned MR
and PET images of the three vertical markers are shown. The black
center demarks the MRmarker signal overlaying the coarser marker
signal of the PET acquisition.
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(Figure 5G ) is visually apparent. However, the 3-hour static image of
PET (Figure 5J ) does not show the hot rim present in the DAR im-
age. Considering the fact that the static image of the late PET scan
and the DAR have grossly different (∼40-fold) resolution, the voxel-
averaging effect of PET needs to be taken into account to understand
this discrepancy (see the Discussion section). It is also important to
note the apparent discrepancy between the significant rim activity of
18F-Fmiso in the DAR and the apparent lack of pimonidazole posi-
tivity in this region. Given the likelihood that the rim of this slice is
well perfused, as may be inferred from the Akep map (Figure 5K ), we
hypothesize that the high-intensity region of 18F-Fmiso around the
tumor rim in the tissue section contains radioactivity that did not
fully wash-out from the perfused area (see the Discussion section).
In principle, the late slope map of 18F-Fmiso (Figure 5C ), or the
wa × k3 parametric map from compartment modeling (Figure 5D)
should eliminate false-positive hypoxic regions such as this; however,
in this particular case, the issue is complicated by the voxel-averaging
effect. Overall, the spatial congruence of the pimonidazole-stained
section, the late 18F-Fmiso slope map (Figure 5C ), and the wa ×
k3 parametric map from compartment modeling (Figure 5D) sug-
gests that the dynamic acquisition of 18F-Fmiso PET provides a more
reliable way of identifying regions of hypoxia than a late static 18F-
Fmiso image.
In Figure 6, the relationship between Akep map (A) and early 18F-
Fmiso uptake values (B) and late 18F-Fmiso slope (C) for tumors of
varying sizes are shown. Small tumors (∼500 mm3) were uniformly
well perfused, as could be seen in both, the DCE Akep maps (Fig-
ure 6A-1) and early 18F-Fmiso uptake PET images (Figure 6B-1). The
corresponding voxel-by-voxel scatterplots were rather concentrated at
higher values over a small dynamic range (Figure 6D-1) and show
a weak positive correlation between DCE Akep and early 18F-Fmiso
uptake (R ∼ 0.2). Intermediate-sized tumors (500 to ∼1200 mm3;
Figure 6, A-2 and A-3) were well perfused around the rim of the
tumor with high DCE Akep values and high early PET uptake val-
ues (Figure 6, B-2 and B-3). The voxel-by-voxel scatterplot demon-
strated higher positive correlations (R = 0.5∼0.7; Figure 6, D-2 and
D-3) with values distributed over a larger dynamic range than for the
smaller well-perfused tumors. For large tumors (>1500 mm3; Fig-
ure 6A-4 ), the necrotic portion appears to be dominant, and the pos-
itive correlation between DCE Akep values and early 18F-Fmiso PET
values is again poorer (R ∼ 0.3; Figure 6D-4 ). These features can be
understood in terms of the development of hypoxic and necrotic re-
gions as the tumor grows, which is true for the R3327-AT tumor
model used in this study [31,32].
The direct spatial relationship between flow/perfusion as repre-
sented by DCE-MRI Akep parametric maps and hypoxia as repre-
sented by late 18F-Fmiso PET slope map was evaluated in their
adequacy to address the fundamental relationship between tumor mi-
crovasculature and hypoxia. Small tumors (∼500 mm3; Figure 6A-1),
which appear to be uniformly well perfused, exhibit uniformly neg-
ative values in the corresponding late 18F-Fmiso slope maps (Fig-
ure 6C-1) and, thus, predictably, appear to be nonhypoxic. The
Figure 4. Characteristic dynamic uptake curves of Gd-DTPA–assisted DCE-MRI (A) and 18F-Fmiso PET (B) for different tumor microen-
vironments (×, perfused area; ○, hypoxic area; •, necrotic area). Perfused, necrotic, and hypoxic areas were independently selected
from DCE-MRI (C), H&E (F), pimonidazole (D) and late Fmiso slope (E) images, respectively, and corresponding dynamic curves are
plotted in A and B.
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Figure 5. (A) Early (5 minutes) 18F-Fmiso uptake values of representative tumor (1230 mm3). (B) The w0 (grade of perfusion) map from
the compartment modeling of the dynamic PET signal. (C) Late slope map (last 1 hour of acquisition) of later 18F-Fmiso PET. (D) wa × k3
(the extent of hypoxia) map from the compartment modeling of the dynamic PET signal. (E) Scatterplot comparing voxel-by-voxel early
18F-Fmiso uptake with w0. (F) Scatterplot comparing voxel-by-voxel the late slope map of 18F-Fmiso PET with wa × k3. (J) A static PET
intensity image at 3 hours after injection. (K) DCE Akep map. G, H, and I are 18F-Fmiso autoradiography, pimonidazole staining (PIMO),
and H&E staining, respectively.
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voxel-by-voxel scatterplot between late 18F-Fmiso slope and Akep
shows a weak (R ∼ −0.2) but significant (P < .001) negative correla-
tion (Figure 6E-1). For intermediate-size heterogeneous tumors, the
regions of positive slopes appeared mainly in the less-perfused areas,
and there were stronger negative correlations (R ∼ −0.35) between
DCE-MRI Akep and the late slope 18F-Fmiso PET curves (Figure 6,
C-2, C-3, E-2, and E-3). As the size of the tumors increases beyond
1500 mm3, no significant uptake of 18F-Fmiso was observed above the
Figure 6. The rows of A, B, and C show DCE-Akep map, early (5 minutes) 18F-Fmiso uptake values, and slope map of later 18F-Fmiso
curve for a slice from four different animals (numbered 1 to 4), respectively. The rows of D and E plot voxel-by-voxel scatterplots for the
direct comparison of these quantities. The tumor sizes are 478 mm3 (1), 744 mm3 (2), 870 mm3 (3), and 2531 mm3 (4).
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noise level except in some parts of the tumor rim, matching the Gd-
DTPA uptake pattern for this large tumor (Figure 6, C-4 and E-4 ).
Figure 7 and Figure W1 relate the values of DCE-MRI Akep to
H&E staining for two representative tumor slices each from a differ-
ent animal. The T2-weighted MR image of the tumor slice (Figure 7A
and Figure W1A) and the corresponding H&E slice (Figure 7B and
Figure W1B) are shown. It was apparent in both tissue sections that
higher values of Akep (Figure 7C and Figure W1C ) correspond to
the viable tumor and lower values of Akep match well with the ne-
crotic area, as estimated from the corresponding H&E slice (Fig-
ure 7B and Figure W1B). For further quantification, a mask was
generated based on the H&E staining to distinguish viable from ne-
crotic tumor regions and was mapped onto the Akep map, as shown
in Figure 7, D and E , and Figure W1, D and E , followed by histo-
gram analysis. The histogram analysis (Figure 7F and Figure W1F )
further confirmed the discrimination that the Akep values could
achieve between viable and necrotic areas. The median Akep values
for viable tumor regions were significantly higher than those of ne-
crotic regions (P < .001). The amount of overlap was dependent on
the individual tumor (Figure 7F and Figure W1F ), suggesting that at
the extreme tails of the distribution curves of the Akep values, there
may be some minimal overlap between necrotic and viable tissue.
However, the shapes of the histograms are markedly different allow-
ing discrimination between viable and necrotic tissue.
Figure 8 relates the slope map of late 18F-Fmiso PET uptake to
regions of pimonidazole-defined hypoxia. A qualitative similarity be-
tween the staining in the pimonidazole section designating hypoxia
(Figure 8A and Figure W2A) and the late 18F-Fmiso slope map
(Figure 8B and Figure W2B) was observed, with higher slope values
generally corresponding to more intense pimonidazole staining. Pi-
monidazole positivity masks (see the Autoradiography, Immunofluo-
rescence, and Histology section) were applied to the slope maps of
the late 18F-Fmiso PET images to distinguish values corresponding
to the hypoxic tumor regions (Figure 8C and Figure W2C ) versus
nonhypoxic tumor regions (Figure 8D and Figure W2D). The over-
lap was considerable, but histogram analysis showed a difference in
the slope values between the hypoxic and nonhypoxic areas (Fig-
ure 8E and Figure W2E ). The volume-averaging effect in coarser-
resolution PET images appeared to be substantial and may be largely
responsible for the overlap. However, the overlap between slope val-
ues of hypoxic and nonhypoxic regions was of concern and would
need to be addressed before possible future clinical use.
Discussion
Multimodality imaging, specifically, DCE-MRI and dynamic 18F-
Fmiso PET, was performed on the R3327-AT preclinical tumor
model. Corresponding tissue sections were stained with H&E and
pimonidazole to relate the noninvasive, in vivo MRI/PET data to
Figure 7. T2-weighted MR image of a slice from one animal (A), corresponding H&E-stained tissue section (B), and corresponding DCE
Akep map (C). D and E are the masked Akep values for the necrotic and viable tumor areas, respectively. The histograms in (F) plot the
Akep values for viable and necrotic tumor areas, respectively. The median Akep values for viable tumor regions were significantly higher
(P < .001) than those of necrotic regions. The tumor size was 744 mm3.
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the tumor microenvironment as determined from ex vivo analysis of
tissue sections. The relationships between coregistered MRI and PET
parameters were investigated. A perfusion-related parameter (Akep)
derived from DCE-MRI yielded a positive correlation with early
18F-Fmiso PET intensity and a negative correlation with late slope
map of 18F-Fmiso PET time-activity curve.
In vivo multimodality MRI/PET imaging of the tumor microen-
vironment promises many advantages for obtaining prognostic infor-
mation about tumor progression or tumor response to treatment;
however, caution needs to be exercised when interpreting such imag-
ing data. Two issues, in particular, should be considered based on our
experimental observations as briefly mentioned in the Experimental
Results section.
Voxel-Averaging Effect in PET
Pimonidazole staining in Figure 4D showed significant staining on
the right rim region of the tumor section adjacent to the perfused
area as determined from DCE-MRI in Figure 4C . Conversely, the
slope map derived from the dynamic PET images (Figure 4E ) did
not indicate any hypoxia in the corresponding rim region. A similar
behavior was also shown for the rim of the tumor in Figure 5, where
there is thin pimonidazole staining around the rim of tumor (Fig-
ure 5H ) and a broader distribution of 18F activity in the DAR (Fig-
ure 5G ) but not in the in vivo PET images (Figure 5, C , D, and
J ). This effect is likely due to the volume averaging of PET result-
ing from its lower spatial resolution (FWHM: 2 mm) compared with
other imaging modalities, particularly microscopy of tissue sections
(0.85 μm × 0.85 μm per pixel at 100× magnification). This problem
is exacerbated if the hypoxic region is located close to the well-perfused
areas. To depict the effect of volume averaging, Gaussian blurring was
applied to the original DAR (Figure 9). Figure 9A-2 shows 40-fold
blurred data, corresponding to the approximate FWHM resolution
obtained from microPET imaging with no distinctive hot spots around
the rim of tumor; this agrees well with the corresponding late-time
(3 hours) static PET image (Figure 5J ). Hypoxia imaging using
MRI/PET is highly sensitive and specific to tumor hypoxia if the
area of hypoxia is similar to the voxel size of the imaging modality
used. Smaller hypoxic regions located close to necrotic or perfused
tumor areas or intermittent hypoxic regions may otherwise not be de-
tectable using these in vivo imaging modalities because of the voxel-
averaging effect.
Perfusion Effect of 18F-Fmiso Accumulation in a Tumor
It is observed that the initial uptake of 18F-Fmiso is dominated by
perfusion (Figures 5 and 6). It is also shown from the 18F-Fmiso time-
activity curve of 18F-Fmiso PET that there exists a crossover point of
Figure 8. (A) Pimonidazole-stained (PIMO) section. (B) Late slope map of 18F-Fmiso PET uptake curves. C and D are masked later 18F-
Fmiso PET slope values for hypoxic and nonhypoxic areas of the tumors, respectively. (E) Histogram plots of the late 18F-Fmiso PET
slope values for hypoxic and nonhypoxic areas of the tumors. The median values of later 18F-Fmiso PET slope for hypoxic regions were
significantly higher (P < .001) than those of nonhypoxic regions, but there was significant overlap. The tumor size was 744 mm3.
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signal intensity between well-perfused and hypoxic areas (Figure 4B).
Awareness of this crossover effect is critical if a static 18F-Fmiso PET
image is used for the detection of hypoxic regions of the tumor. Our
data show that different tumors are unlikely to have similar crossover
time point because the tumor microenvironment could be very dif-
ferent. To address the hypothesis that the high-intensity region of
18F-Fmiso around the tumor rim in the tissue section contains radio-
activity, which did not fully wash out from the perfused area, the
tumor section was washed in PBS for 1, 5, and 30 minutes to remove
any unbound 18F-Fmiso and was radiographically evaluated. The
images at the bottom row of Figure 9 depict the DARs of the frozen
section (Figure 9B-1) and after a 30-minute wash in PBS (Figure 9B-
2). The signal-to-noise ratio of activity drops significantly even after
the first wash, and the thickness of the rim is continually reduced
with each wash, eventually approaching the corresponding image
of pimonidazole (Figures 5H and 9B-2). The size of the hot spot
in the 18F autoradiogram of the slice (Figure 9, B-1 and B-2) decreased
with each wash as well and closely approximates the size and location
of the intense spot in the pimonidazole-stained section (Figure 5H )
and late slope map of 18F-Fmiso (Figure 5C ). The possibility of intro-
ducing unbound 18F-Fmiso during tissue sectioning cannot be fully
excluded when explaining the visible hot rim in DAR, although it is
considered less likely.
Also, other aspects related to the sequential acquisition of the MR
and PET data in this study need to be considered. The fiduciary
marker system and the molding of the animal with the tumor grown
on the leg allow stable positioning of the tumor between the MR and
PET acquisitions and thus coregistration of the MR and PET images
using a rigid transformation. However, in a clinical setting, the tumor
may be deformable and/or may be susceptible to both voluntary and
involuntary (e.g., respiratory) patient motions. Thus, image coregis-
tration would need to account for motion or tissue deformation,
which is a more complex problem to solve and less robust than a
rigid transformation. This could be further aggravated by significant
tissue movement present between the two imaging studies and would
most likely result in larger coregistration errors than can be expected
in the current study. Also, performing the MR and PET acquisition
sequentially assumes that the gross tumor physiology does not change
between the experiments. Simultaneous acquisition of the MR and
PET images would therefore be highly desirable. The recent devel-
opments of combined MR/PET systems (preclinical and clinical
[33–36]), which allow such simultaneous image acquisition, will be
invaluable in pursuing studies such as those presented in this article.
Previous clinical studies support the importance of measuring
both tumor perfusion and hypoxia [37,38]. Bruehlmeier et al. [37]
showed in a PET study of human brain tumors that the initial uptake
of 18F-Fmiso was perfusion-dependent, whereas late uptake was in-
dependent of perfusion. Thorwarth et al. [38] showed in a PET study
of human head-and-neck cancers that hypoxia and perfusion were
independent from each other but both affected radiation treatment
outcome. Their data clearly illustrate the need for both perfusion
and hypoxia measurements to investigate the tumor microenviron-
ment. Although perfusion and hypoxia were found to be indepen-
dent, their results emphasize the interaction of these parameters. The
combined measurements of both hypoxia and perfusion were shown to
be clinically predictive of outcome, whereas neither parameter alone
was related to outcome. The clinical data cited support the validity
and relevance of the preclinical data presented in this article because
the tumor microenvironment in both preclinical and clinical studies
demonstrates significant heterogeneity in perfusion and hypoxia. Thus,
the potential utility of further clinical and preclinical studies to evaluate
perfusion, hypoxia, and their relationship to outcome is warranted.
Bearing in mind the caveats listed above, the combination of DCE-
MRI and 18F-Fmiso PET could be proposed as noninvasive clinical
imaging tool in the evaluation of tumor prognosis, planning for radi-
ation therapy or chemotherapy, and monitoring of treatment response.
These noninvasive imaging modalities have particular promise because
they provide not only anatomically but also clinically important func-
tional information of the tumor microenvironment.
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Figure W1. T2-weighted MR image of a slice from one animal (A), corresponding H&E-stained tissue section (B), and corresponding DCE
Akep map (C). D and E are the masked Akep values for the necrotic and viable tumor areas, respectively. The histograms in F plot the
Akep values for viable and necrotic tumor areas, respectively. The median Akep values for viable tumor regions were significantly higher
(P < .001) than those of necrotic regions. The tumor size was 870 mm3.
Figure W2. (A) Pimonidazole-stained (PIMO) section. (B) Late slope map of 18F-Fmiso PET uptake curves. C and D are masked later 18F-
Fmiso PET slope values for hypoxic and nonhypoxic areas of the tumors, respectively. (E) Histogram plots of the late 18F-Fmiso PET
slope values for hypoxic and nonhypoxic areas of the tumors. The median values of later 18F-Fmiso PET slope for hypoxic regions were
significantly higher (P < .001) than those of nonhypoxic regions, but there was significant overlap. The tumor size was 870 mm3.
